keyword
https://read.qxmd.com/read/38330495/-first-experience-in-mexico-with-plasmapheresis-and-rituximab-treating-humoral-rejection-in-heart-transplant
#1
JOURNAL ARTICLE
Gustavo Inzunza-Cervantes, José A Cigarroa-Lopéz, Antonio Tepayotl-Aponte, Raúl Martínez-Castro, José A Magaña-Serrano, Juan B Ivey-Miranda
No abstract text is available yet for this article.
February 8, 2024: Archivos de Cardiología de México
https://read.qxmd.com/read/38326154/scedosporium-boydii-finding-in-an-immunocompromised-patient-and-review-of-the-literature
#2
JOURNAL ARTICLE
Silvana Ramadán, Hernán Dalmaso, Alicia Luque, Maximiliano Sortino, María Luján Cuestas, Katherine Hermida Alava, Diego Bertola, Lucía Bulacio
BACKGROUND: Scedosporiasis is an emerging mycosis that has gained importance in recent years due to its worldwide prevalence. It is caused by species of the Scedosporium apiospermum complex. These species can cause opportunistic infections in immunocompromised patients and, occasionally, in immunocompetent patients as well. The high intrinsic antifungal resistance make these infections difficult to manage. AIMS: The objective of this study was to interpret the mycological findings in a transplant patient, together with the images obtained in the radiological studies, in order to provide an early and effective antifungal therapy...
February 6, 2024: Revista Iberoamericana de Micología
https://read.qxmd.com/read/37984725/prognosis-factors-in-heart-lung-transplantation-30-years-experience-in-a-reference-center
#3
JOURNAL ARTICLE
Carlos Ordoñez Ochoa, Jose Cerón Navarro, Olga Salamea Ávila, Alilis Fontana Bellorín, Stephania Aguilar Gonzalez, Alfonso Morcillo Aixelá, Carlos Jorda Aragón, Gabriel Sales Badia
INTRODUCTION: Heart-lung transplantation has shown a progressive decrease in the number of procedures. There is a lack of information about this field in Spain. The main goal of this study is to analyze the experience of a national reference hospital. METHODS: We performed a retrospective study of a historical cohort of heart-lung transplanted patients in a single center, during a 30 years period (from 1990 to 2021). The associations between variables were evaluated using the χ2 test or Fisher's exact test...
January 2024: Cirugia española
https://read.qxmd.com/read/37984703/prognosis-after-heart-transplant-in-patients-with-hypertrophic-and-restrictive-cardiomyopathy-a-nationwide-registry-analysis
#4
JOURNAL ARTICLE
Francisco González Urbistondo, Luis Almenar Bonet, Manuel Gómez Bueno, Marisa Crespo Leiro, Francisco González Vílchez, María Dolores García-Cosío, Amador López Granados, Sonia Mirabet, Manuel Martínez Sellés, José Manuel Sobrino, Carles Díez López, Marta Farrero, Beatriz Díaz Molina, Gregorio Rábago, Luis De La Fuente-Galán, Iris Garrido Bravo, María Teresa Blasco-Peiró, Antonio García Quintana, José Antonio Vázquez De Prada
INTRODUCTION AND OBJECTIVES: Posttransplant outcomes among recipients with a diagnosis of hypertrophic cardiomyopathy (HCM) or restrictive cardiomyopathy (RCM) remain controversial. METHODS: Retrospective analysis of a nationwide registry of first-time recipients undergoing isolated heart transplant between 1984 and 2021. One-year and 5-year mortality in recipients with HCM and RCM were compared with those with dilated cardiomyopathy (DCM). RESULTS: We included 3703 patients (3112 DCM; 331 HCM; 260 RCM) with a median follow-up of 5...
November 18, 2023: Revista Española de Cardiología
https://read.qxmd.com/read/37972371/heart-transplantation-in-patients-with-anthracycline-induced-cardiomyopathy
#5
JOURNAL ARTICLE
Santiago L Del-Castillo, Santiago Decotto, María M Fleitas, Ricardo Marenchino, Hernán García-Rivello, Dana Kohan, Rodolfo Pizarro, César A Belziti
OBJECTIVE: The objective of this study was to describe the clinical and imaging characteristics and the evolution of heart transplantation patients due to anthracycline-induced cardiomyopathy. METHODS: Patients with a diagnosis of ACM who received a heart transplantation in our institution in the period of November 2009-April 2021 were included. Clinical characteristics, pre-transplant studies, and clinical outcomes after transplantation were collected retrospectively from the electronic medical record...
2023: Archivos de Cardiología de México
https://read.qxmd.com/read/37972368/cardiac-and-autologous-stem-cell-transplantation-hematopoietic-in-patients-with-al-amyloidosis
#6
JOURNAL ARTICLE
Marcelina Carretero, Eugenia Villanueva, Erika B Brulc, Franco M Faelo, María A Aguirre, Diego Pérez-de-Arenaza, Cesar A Belziti, Jorge A Arbelbide, Elsa M Nucifora, María L Posadas-Martinez
OBJECTIVE: To describe the evolution of serum free light chains (FLC) in the period between orthotopic heart transplantation (OHT) and autologous stem cell transplantation (ASCT), the hematological response one year after ASCT and chemotherapy and immunosuppressive treatment in patients with AL amyloidosis. METHOD: Case series of consecutive patients diagnosed with AL amyloidosis who received OHT followed by ASCT from the Institutional Registry of Amyloidosis of the Italian Hospital of Buenos Aires, between January 2010 and November 2021...
2023: Archivos de Cardiología de México
https://read.qxmd.com/read/37926340/review-of-the-allocation-criteria-for-heart-transplant-in-spain-in-2023-sec-heart-failure-association-ont-secce-consensus-document
#7
JOURNAL ARTICLE
José González-Costello, Alicia Pérez-Blanco, Juan Delgado-Jiménez, Francisco González-Vílchez, Sonia Mirabet, Elena Sandoval, José Cuenca-Castillo, Manuela Camino, Javier Segovia-Cubero, José Carlos Sánchez-Salado, Enrique Pérez De La Sota, Luis Almenar-Bonet, Marta Farrero, Eduardo Zataraín, María Dolores García-Cosío, Iris Garrido, Eduardo Barge-Caballero, Manuel Gómez-Bueno, Javier De Juan Bagudá, Nicolás Manito-Lorite, Amador López-Granados, Luis García-Guereta, Teresa Blasco-Peiró, José Aurelio Sarralde-Aguayo, Manuel Sobrino-Márquez, Luis De La Fuente-Galán, María Generosa Crespo-Leiro, Elisabeth Coll, Ferrán Gran-Ipiña, Beatriz Díaz-Molina, Lucía Doñate, Félix Sánchez-Vicario, Felipe Atienza, Gregorio Rábago Juan-Aracil, Antonio García-Quintana, Itziar Martínez-Alpuente, Fernando Riesgo-Gil, Jaime Hernández-Monfort, Eva Oliver-Juan, Javier Sánchez-Rivas, María Padilla-Martínez, José Miguel Pérez-Villares, Eduardo Miñambres, Beatriz Domínguez-Gil
Heart transplant (HT) remains the best therapeutic option for patients with advanced heart failure (HF). The allocation criteria aim to guarantee equitable access to HT and prioritize patients with a worse clinical status. To review the HT allocation criteria, the Spanish Society of Cardiology and the National Transplant Organization organized a consensus conference involving adult and pediatric cardiologists, adult and pediatric cardiac surgeons, transplant coordinators from all over Spain, and physicians and nurses from the National Transplant Organization...
November 3, 2023: Revista Española de Cardiología
https://read.qxmd.com/read/37683823/spanish-heart-transplant-registry-34th-official-report-of-the-heart-failure-association-of-the-spanish-society-of-cardiology
#8
JOURNAL ARTICLE
Francisco González-Vílchez, Francisco Hernández-Pérez, Luis Almenar-Bonet, María G Crespo-Leiro, Amador López-Granados, Carlos Ortiz-Bautista, Juan F Delgado-Jiménez, Marta de Antonio-Ferrer, José M Sobrino-Márquez, Elena García-Romero
INTRODUCTION AND OBJECTIVES: The Spanish heart transplant registry updates its data annually. The current update presents the data for the year 2022. METHODS: We describe the main clinical characteristics, treatments received, and survival outcomes including procedures performed in 2022, along with their trends since 2013. RESULTS: In 2022, 311 cardiac transplants were performed, representing a 3.0% increase compared with 2021. Compared with previous years, no significant changes in demographic and clinical characteristics were observed in 2022, confirming the trends identified in the last decade...
September 6, 2023: Revista Española de Cardiología
https://read.qxmd.com/read/37678464/heart-transplant-anesthetic-approach-in-a-patient-with-emery-dreyfuss-muscular-dystrophy-a-case-report
#9
I Q Martins, M Cuervo, I Vilhena
Emery-Dreifuss muscular dystrophy is associated with cardiac abnormalities and rarely heart transplantation may be the treatment of choice. In this case, a male patient with Emery- Dreifuss muscular dystrophy developed NYHA class IV heart failure at 33 years of age and was submitted to heart transplantation. Anesthesia was adapted to prevent the development of malignant hyperthermia and rhabdomyolysis. The surgery was a success and the patient's progress was extremely positive with symptomatic improvement. In these patients, is critical to adjust not only his positioning but also the therapy administered in order to reduce iatrogeny and promote a faster recovery...
September 5, 2023: Revista española de anestesiología y reanimación
https://read.qxmd.com/read/37516313/repetitive-ambulatory-levosimendan-as-a-bridge-to-heart-transplantation
#10
JOURNAL ARTICLE
Javier de Juan Bagudá, Fernando de Frutos, Raquel López-Vilella, David Couto Mallón, Joan Guzman-Bofarull, Zorba Blazquez-Bermejo, Manuel Cobo-Belaustegui, Cristina Mitroi, Francisco J Pastor-Pérez, Carlos Moliner-Abós, Diego Rangel-Sousa, Beatriz Díaz-Molina, Javier Tobar-Ruiz, Nahikari Salterain Gonzalez, José Manuel García-Pinilla, María Dolores García-Cosío Carmena, María Generosa Crespo-Leiro, David Dobarro, Luis Almenar, Juan F Delgado-Jiménez, Emilio Paredes-Galán, Francisco González-Vílchez, José González-Costello
INTRODUCTION AND OBJECTIVES: Repetitive ambulatory doses of levosimendan are an option as a bridge to heart transplantation (HT), but evidence regarding the safety and efficacy of this treatment is scarce. The objective of the LEVO-T Registry is to describe the profile of patients on the HT list receiving levosimendan, prescription patterns, and clinical outcomes compared with patients not on levosimendan. METHODS: We retrospectively reviewed all patients listed for elective HT from 2015 to 2020 from 14 centers in Spain...
July 27, 2023: Revista Española de Cardiología
https://read.qxmd.com/read/37217134/use-of-a-surgically-implanted-nondischargeable-extracorporeal-continuous-flow-circulatory-support-system-as-a-bridge-to-heart-transplant
#11
JOURNAL ARTICLE
Gonzalo Cabezón-Villalba, Eduardo Barge-Caballero, Francisco González-Vílchez, María Ángeles Castel-Lavilla, Manuel Gómez-Bueno, Luis Almenar-Bonet, José González-Costello, José Luis Lambert-Rodríguez, Manuel Martínez-Sellés, Luis de la Fuente-Galán, Sonia Mirabet-Pérez, María Dolores García-Cosío Carmena, Daniela Hervás-Sotomayor, Diego Rangel-Sousa, Teresa Blasco-Peiró, Iris P Garrido-Bravo, Gregorio Rábago Juan-Aracil, Javier Muñiz, María G Crespo-Leiro
INTRODUCTION AND OBJECTIVES: We aimed to describe the clinical outcomes of the use of the CentriMag acute circulatory support system as a bridge to emergency heart transplantation (HTx). METHODS: We conducted a descriptive analysis of the clinical outcomes of consecutive HTx candidates included in a multicenter retrospective registry who were treated with the CentriMag device, configured either for left ventricular support (LVS) or biventricular support (BVS). All patients were listed for high-priority HTx...
May 20, 2023: Revista Española de Cardiología
https://read.qxmd.com/read/36930552/experience-acquired-after-34-years-of-the-first-heart-transplantation-in-mexico
#12
JOURNAL ARTICLE
Guillermo Careaga-Reyna
On July 21, 1988, a successful heart transplant was carried out for the first time in Mexico; 34 years later, several hospitals in the country have performed this procedure. We present information and comments on the results obtained within this period at Mexican Social Security Institute La Raza National Medical Center "Dr. Gaudencio González Garza" General Hospital, where 234 transplants have been performed (one out of every three carried out throughout the country), with a short- and mid-term survival comparable to that reported in the rest of the world...
2023: Gaceta Médica de México
https://read.qxmd.com/read/36774246/impact-of-mobilization-in-patients-with-short-term-mechanical-circulatory-support-such-as-levitronix%C3%A2-centrimag-as-a-bridge-to-heart-transplantation
#13
JOURNAL ARTICLE
A Chicano-Corrales, J Bañeras-Rius, F de Frutos, J C Sánchez-Salado, A Ariza-Solé, A Blasco-Lucas, F Sbraga, C Díez-López, E Calvo-Barriuso, J Castillo García, C S Molina-Mazón, A López-López, I Tinoco-Amorós, A Abellán-García, J González-Costello
INTRODUCTION: Despite the benefits of mobilisation in the critical patient, the evidence in patients with Levitronix® CentriMag as a bridge to heart transplantation (HT) is scarce. The objective of this study is to analyze the impact of mobility on these patients. METHODS: Retrospective observational study of patients who received a HT with Levitronix® CentriMag admitted between 2010 and 2019 to a tertiary hospital. Degree of mobility and nutritional status were assessed at the time of HT...
2023: Enfermería intensiva
https://read.qxmd.com/read/36724119/cardiac-transplantation-due-to-hemochromatosis-a-pediatric-case-report
#14
JOURNAL ARTICLE
Carlos Alcántara, María F Mendoza, Dyan G Lúa, Sergio Ruiz, Patricia Romero, Alejandra Contreras-Ramos, Alejandro Bolio
Hemochromatosis is a disease characterized by excess iron stores in multiple organs, including the liver, pancreas, skin, and heart. The infiltration of the heart is an important factor in morbidity and mortality. Here we describe the case of a pediatric patient with end-stage heart failure who required a heart transplantation, with no complications. After the surgery, she showed biochemical and clinical improvement, with a positive impact on her quality of life and a prolonged survival.
February 9, 2023: Archivos Argentinos de Pediatría
https://read.qxmd.com/read/36055642/durable-ventricular-assist-device-in-spain-2007-2020-first-report-of-the-regalad-registry
#15
JOURNAL ARTICLE
Manuel Gómez-Bueno, Enrique Pérez de la Sota, Alberto Forteza Gil, Daniel Ortiz-Berbel, Javier Castrodeza, María Dolores García-Cosío Carmena, Eduardo Barge-Caballero, Diego Rangel Sousa, Beatriz Díaz Molina, Rebeca Manrique Antón, Luis Almenar-Bonet, Aitor Uribarri González, Alfredo Barrio-Rodríguez, María Ángeles Castel Lavilla, Laura López-López, David Dobarro Pérez, Francisco Pastor Pérez, Virginia Burgos-Palacios, Jesús Álvarez-García, José Manuel Garrido-Jiménez, Óscar González-Fernández, Pau Codina, Amador López-Granados, Andrés Grau-Sepulveda, José González-Costello
INTRODUCTION AND OBJECTIVES: This report presents the clinical characteristics, outcomes and complications of all consecutive patients implanted with a long-term mechanical circulatory support device in Spain between 2007 and 2020. METHODS: Analysis of the Spanish Registry of durable ventricular assist devices (REGALAD) including data form Spanish centers with a mechanical circulatory support program. RESULTS: During the study period, 263 ventricular assist devices were implanted in 22 hospitals...
August 30, 2022: Revista Española de Cardiología
https://read.qxmd.com/read/35850486/spanish-heart-transplant-registry-33rd-official-report-of-the-heart-failure-association-of-the-spanish-society-of-cardiology
#16
JOURNAL ARTICLE
Francisco González-Vílchez, Manuel Gómez-Bueno, Luis Almenar-Bonet, María G Crespo-Leiro, José M Arizón Del Prado, Zorba Blázquez-Bermejo, Juan F Delgado-Jiménez, Marta de Antonio-Ferrer, José M Sobrino-Márquez, Elena García-Romero
INTRODUCTION AND OBJECTIVES: This report updates the annual data of the Spanish Heart Transplant Registry with the procedures performed in 2021. METHODS: We describe the clinical profile, therapeutic characteristics and outcomes in terms of survival of the procedures performed in 2021. Their temporal trends are updated for the 2012 to 2020 period. RESULTS: In 2021, 302 heart transplants were performed (8.6% increase versus 2020). The tendency in 2021 confirmed that of prior years, with fewer urgent transplants and a preference for the use of ventricular assist devices...
July 16, 2022: Revista Española de Cardiología
https://read.qxmd.com/read/35763820/heart-transplantation-in-mexico-2006-2019-productivity-analysis-and-pan-american-and-iberian-comparison
#17
JOURNAL ARTICLE
Rubén Argüero-Sánchez, Enrique M Olivares-Durán, Omar Sánchez-Ramírez
INTRODUCTION: In Mexico, heart transplants (HTs) have been performed since 1988. OBJECTIVE: To review Mexican productivity in terms of HT between 2006 and 2019 and compare it with that of American and Iberian Peninsula countries. METHODS: Mexican information was collected from HT waiting lists (WL) and from the HTs carried out annually in the period, and was expressed as rates per million population (pmp); 2019 information was compared with that reported at the Pan American and Iberian levels...
2022: Gaceta Médica de México
https://read.qxmd.com/read/35680367/heart-transplantation-in-systemic-sclerosis-a-therapeutic-option-presentation-of-a-case-and-literature-review
#18
Andrea de Diego-Sola, César A Egües Dubuc, Cristina Goena Vives, Juan José Intxausti Irazabal, Olga Maíz Alonso, Manuel Cobo Belaustegi
Cardiac involvement in systemic sclerosis (SSc) is rare but leads to poor short-term prognosis. Evidence regarding heart transplantation (HT) is scarce and is based on experience with isolated cases. We present this case with the aim of analysing the characteristics of a patient with SS who has undergone a successful transplant.
June 2022: Reumatología clinica
https://read.qxmd.com/read/34633949/-ischemic-cardiogenic-shock-and-short-term-mechanical-circulatory-support-as-bridge-to-transplantation
#19
JOURNAL ARTICLE
María F Renedo, Chen Chao, Roberto R Favaloro, Daniel O Absi, Alejandro M Bertolotti, Carlos A Vigliano
Cardiogenic shock (CS) has a high mortality rate and often requires advanced therapies such as mechanical circulatory support (MCS) and heart transplantation (HT). Those patients who presented an acute myocardial infarction (AMI) with CS and required support through MCS as bridge to HT were retrospectively analyzed in a single Center. Between January 1997 and June 2020, 524 patients received HT, 203 for ischemic-cardiomyopathy, 103 were in emergency waiting list. Eleven patients met the inclusion criteria (mean age 53 ± 11 years old; men 73%)...
2021: Medicina
https://read.qxmd.com/read/34562415/factors-associated-with-return-to-work-after-heart-transplantation-a-systematic-review-of-the-literature
#20
JOURNAL ARTICLE
Edilma L Rivera, Julián Aponte, Maria C Montes, Christian D Adams, Juan E Gómez-Mesa
BACKGROUND: Heart transplantation represents one of the last treatment options for advanced heart failure. Little is known about the factors associated with return to work in patients after heart transplantation. The aim of this study is to identify those factors. METHODS: A systematic literature review was conducted in the PubMed, LILACS, SCIELO and ScienceDirect databases using the keywords "trasplante cardiaco", "calidad de vida", "reingreso laboral", "return to work", "heart transplantation" and "occupation related"...
September 22, 2021: American Journal of the Medical Sciences
keyword
keyword
28125
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.